| Name | Title | Contact Details |
|---|
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.
EmCare Holdings Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. EmCare Holdings Inc. is based in Dallas, TX. You can find more information on EmCare Holdings Inc. at www.emcare.com
EPOCH offers a 401(k) Retirement Savings Plan, with a variety of 25 fund options ranging from low to high risk, to choose from.
Opya, Inc. is changing how autism care is delivered for children newly diagnosed with autism & and transforming the lives of neuro-diverse children & their families. For in-home ABA therapy services in the Bay Area, contact us today!
Pharmaka is a Flemington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.